annual D&A:
$3.26B+$405.80M(+14.22%)Summary
- As of today (May 20, 2025), GSK annual depreciation & amortization is $3.26 billion, with the most recent change of +$405.80 million (+14.22%) on December 31, 2024.
- During the last 3 years, GSK annual D&A has risen by +$340.95 million (+11.68%).
- GSK annual D&A is now at all-time high.
Performance
GSK Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.04B+$559.32M(+117.27%)Summary
- As of today (May 20, 2025), GSK quarterly depreciation & amortization is $1.04 billion, with the most recent change of +$559.32 million (+117.27%) on March 31, 2025.
- Over the past year, GSK quarterly D&A has increased by +$339.92 million (+48.82%).
- GSK quarterly D&A is now -66.11% below its all-time high of $3.06 billion, reached on December 31, 2020.
Performance
GSK quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$3.60B+$339.92M(+10.43%)Summary
- As of today (May 20, 2025), GSK TTM depreciation & amortization is $3.60 billion, with the most recent change of +$339.92 million (+10.43%) on March 31, 2025.
- Over the past year, GSK TTM D&A has increased by +$827.29 million (+29.83%).
- GSK TTM D&A is now -35.25% below its all-time high of $5.56 billion, reached on September 30, 2021.
Performance
GSK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GSK Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | +48.8% | +29.8% |
| 3 y3 years | +11.7% | +84.8% | +20.7% |
| 5 y5 years | +9.4% | +316.8% | +113.3% |
GSK Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.6% | -19.3% | +2854.4% | at high | +73.2% |
| 5 y | 5-year | at high | +23.9% | -66.1% | +171.3% | -35.3% | +585.4% |
| alltime | all time | at high | +1063.6% | -66.1% | +171.3% | -35.3% | +585.4% |
GSK Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.04B(+117.3%) | $3.60B(+10.4%) |
| Dec 2024 | $3.26B(+14.2%) | $476.95M(-62.9%) | $3.26B(-7.4%) |
| Sep 2024 | - | $1.28B(+60.0%) | $3.52B(+17.9%) |
| Jun 2024 | - | $802.54M(+15.3%) | $2.99B(+7.7%) |
| Mar 2024 | - | $696.35M(-5.7%) | $2.77B(-2.9%) |
| Dec 2023 | $2.85B(+7.4%) | $738.56M(-1.4%) | $2.85B(+37.3%) |
| Sep 2023 | - | $749.10M(+27.2%) | $2.08B(-11.5%) |
| Jun 2023 | - | $588.90M(-24.3%) | $2.35B(-18.4%) |
| Mar 2023 | - | $777.92M(-2167.7%) | $2.88B(+8.2%) |
| Dec 2022 | $2.66B(-8.9%) | -$37.62M(-103.7%) | $2.66B(-14.6%) |
| Sep 2022 | - | $1.02B(-8.9%) | $3.11B(-6.5%) |
| Jun 2022 | - | $1.12B(+99.3%) | $3.33B(+11.7%) |
| Mar 2022 | - | $560.82M(+34.5%) | $2.98B(+2.2%) |
| Dec 2021 | $2.92B(+11.0%) | $416.84M(-66.3%) | $2.92B(-47.5%) |
| Sep 2021 | - | $1.24B(+60.8%) | $5.56B(+9.0%) |
| Jun 2021 | - | $768.74M(+54.5%) | $5.10B(+77.1%) |
| Mar 2021 | - | $497.64M(-83.7%) | $2.88B(+9.5%) |
| Dec 2020 | $2.63B(-11.7%) | $3.06B(+293.1%) | $2.63B(-634.6%) |
| Sep 2020 | - | $777.70M(-153.5%) | -$492.15M(-33.6%) |
| Jun 2020 | - | -$1.45B(-684.3%) | -$741.63M(-143.9%) |
| Mar 2020 | - | $248.65M(-478.4%) | $1.69B(-43.4%) |
| Dec 2019 | $2.98B(+20.3%) | -$65.71M(-112.4%) | $2.98B(-25.5%) |
| Sep 2019 | - | $528.22M(-45.9%) | $4.00B(-1.9%) |
| Jun 2019 | - | $976.53M(-36.6%) | $4.08B(+21.6%) |
| Mar 2019 | - | $1.54B(+61.6%) | $3.35B(+35.4%) |
| Dec 2018 | $2.48B(-0.2%) | $953.59M(+57.4%) | $2.48B(+96.6%) |
| Sep 2018 | - | $605.67M(+139.9%) | $1.26B(-20.9%) |
| Jun 2018 | - | $252.45M(-62.0%) | $1.59B(-41.9%) |
| Mar 2018 | - | $664.66M(-352.3%) | $2.74B(+10.5%) |
| Dec 2017 | $2.48B(+3.2%) | -$263.41M(-128.1%) | $2.48B(-31.8%) |
| Sep 2017 | - | $938.76M(-33.1%) | $3.64B(+28.4%) |
| Jun 2017 | - | $1.40B(+247.4%) | $2.83B(+41.0%) |
| Mar 2017 | - | $403.77M(-54.8%) | $2.01B(-16.4%) |
| Dec 2016 | $2.40B(-3.5%) | $893.04M(+571.4%) | $2.40B(+25.5%) |
| Sep 2016 | - | $133.01M(-77.0%) | $1.92B(-11.5%) |
| Jun 2016 | - | $578.76M(-27.5%) | $2.17B(-19.9%) |
| Mar 2016 | - | $798.79M(+97.1%) | $2.70B(+8.5%) |
| Dec 2015 | $2.49B(+1.8%) | $405.30M(+6.0%) | $2.49B(+7.7%) |
| Sep 2015 | - | $382.41M(-65.8%) | $2.31B(-9.4%) |
| Jun 2015 | - | $1.12B(+90.4%) | $2.55B(+22.5%) |
| Mar 2015 | - | $586.60M(+158.0%) | $2.08B(-14.8%) |
| Dec 2014 | $2.45B(+10.6%) | $227.34M(-63.5%) | $2.45B(+54.4%) |
| Sep 2014 | - | $623.48M(-3.7%) | $1.58B(-24.9%) |
| Jun 2014 | - | $647.29M(-31.7%) | $2.11B(-7.9%) |
| Mar 2014 | - | $948.08M(-249.4%) | $2.29B(+3.6%) |
| Dec 2013 | $2.21B(-3.4%) | -$634.68M(-155.2%) | $2.21B(-43.9%) |
| Sep 2013 | - | $1.15B(+38.7%) | $3.94B(+22.7%) |
| Jun 2013 | - | $828.96M(-4.5%) | $3.22B(+15.6%) |
| Mar 2013 | - | $868.33M(-20.9%) | $2.78B(+21.5%) |
| Dec 2012 | $2.29B(+0.3%) | $1.10B(+160.6%) | $2.29B(+44.3%) |
| Sep 2012 | - | $421.22M(+6.9%) | $1.59B(-23.8%) |
| Jun 2012 | - | $393.95M(+4.5%) | $2.08B(-15.0%) |
| Mar 2012 | - | $376.98M(-4.5%) | $2.45B(+7.4%) |
| Dec 2011 | $2.28B | $394.68M(-56.9%) | $2.28B(+5.6%) |
| Sep 2011 | - | $916.43M(+20.2%) | $2.16B(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $762.46M(+266.1%) | $2.18B(+5.1%) |
| Mar 2011 | - | $208.25M(-24.0%) | $2.07B(-20.0%) |
| Dec 2010 | $2.59B(+5.8%) | $274.09M(-70.6%) | $2.59B(-4.6%) |
| Sep 2010 | - | $930.95M(+41.8%) | $2.71B(+2.9%) |
| Jun 2010 | - | $656.68M(-9.6%) | $2.64B(+14.4%) |
| Mar 2010 | - | $726.65M(+81.8%) | $2.31B(-5.7%) |
| Dec 2009 | $2.45B(+7.5%) | $399.64M(-53.3%) | $2.45B(+0.0%) |
| Sep 2009 | - | $855.43M(+163.2%) | $2.45B(+6.9%) |
| Jun 2009 | - | $324.95M(-62.5%) | $2.29B(-9.5%) |
| Mar 2009 | - | $866.64M(+117.0%) | $2.53B(+11.1%) |
| Dec 2008 | $2.28B(+11.2%) | $399.29M(-42.8%) | $2.28B(+10.2%) |
| Sep 2008 | - | $698.10M(+23.3%) | $2.07B(-5.5%) |
| Jun 2008 | - | $566.12M(-7.7%) | $2.19B(+2.9%) |
| Mar 2008 | - | $613.03M(+226.4%) | $2.12B(+3.8%) |
| Dec 2007 | $2.05B(+15.9%) | $187.81M(-77.1%) | $2.05B(+4.3%) |
| Sep 2007 | - | $819.15M(+62.2%) | $1.96B(+12.9%) |
| Jun 2007 | - | $504.98M(-5.7%) | $1.74B(-8.3%) |
| Mar 2007 | - | $535.58M(+421.0%) | $1.90B(+7.3%) |
| Dec 2006 | $1.77B(+7.4%) | $102.80M(-82.7%) | $1.77B(-16.4%) |
| Sep 2006 | - | $594.52M(-10.3%) | $2.11B(+8.8%) |
| Jun 2006 | - | $662.51M(+63.0%) | $1.94B(+9.6%) |
| Mar 2006 | - | $406.44M(-9.7%) | $1.77B(+7.8%) |
| Dec 2005 | $1.64B(+4.5%) | $450.23M(+6.4%) | $1.64B(+55.1%) |
| Sep 2005 | - | $423.25M(-14.1%) | $1.06B(-13.5%) |
| Jun 2005 | - | $492.77M(+77.3%) | $1.23B(-4.0%) |
| Mar 2005 | - | $277.96M(-308.0%) | $1.28B(-18.9%) |
| Dec 2004 | $1.57B(+12.0%) | -$133.62M(-122.7%) | $1.57B(-18.7%) |
| Sep 2004 | - | $589.10M(+8.4%) | $1.94B(-1.6%) |
| Jun 2004 | - | $543.35M(-5.5%) | $1.97B(+14.4%) |
| Mar 2004 | - | $575.00M(+152.2%) | $1.72B(+22.3%) |
| Dec 2003 | $1.40B(+13.4%) | $228.01M(-63.2%) | $1.40B(-1.5%) |
| Sep 2003 | - | $619.59M(+109.3%) | $1.43B(+19.0%) |
| Jun 2003 | - | $296.00M(+13.3%) | $1.20B(+4.8%) |
| Mar 2003 | - | $261.25M(+4.6%) | $1.14B(-7.6%) |
| Dec 2002 | $1.24B(+5.8%) | $249.87M(-36.2%) | $1.24B(-10.1%) |
| Sep 2002 | - | $391.83M(+62.2%) | $1.38B(+5.0%) |
| Jun 2002 | - | $241.50M(-32.0%) | $1.31B(-0.0%) |
| Mar 2002 | - | $355.16M(-8.6%) | $1.31B(+12.0%) |
| Dec 2001 | $1.17B(+5.1%) | $388.41M(+19.1%) | $1.17B(-38.3%) |
| Sep 2001 | - | $326.19M(+35.1%) | $1.90B(+40.4%) |
| Jun 2001 | - | $241.50M(+12.5%) | $1.35B(+29.4%) |
| Mar 2001 | - | $214.63M(-80.7%) | $1.04B(-6.2%) |
| Dec 2000 | $1.11B(+60.9%) | $1.11B(-608.7%) | $1.11B(>+9900.0%) |
| Sep 2000 | - | -$219.01M(+236.1%) | $100.00(-100.0%) |
| Jun 2000 | - | -$65.17M(-122.9%) | $219.01M(-22.9%) |
| Mar 2000 | - | $284.19M | $284.19M |
| Dec 1999 | $692.55M(+16.7%) | - | - |
| Dec 1998 | $593.35M(-2.9%) | - | - |
| Dec 1997 | $611.06M(-4.6%) | - | - |
| Dec 1996 | $640.38M(-23.9%) | - | - |
| Dec 1995 | $841.29M(+61.3%) | - | - |
| Jun 1995 | $521.47M(+23.6%) | - | - |
| Jun 1994 | $422.06M(+15.4%) | - | - |
| Jun 1993 | $365.73M(+8.9%) | - | - |
| Jun 1992 | $335.99M(+19.9%) | - | - |
| Jun 1991 | $280.18M | - | - |
FAQ
- What is GSK annual depreciation & amortization?
- What is the all time high annual D&A for GSK?
- What is GSK annual D&A year-on-year change?
- What is GSK quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GSK?
- What is GSK quarterly D&A year-on-year change?
- What is GSK TTM depreciation & amortization?
- What is the all time high TTM D&A for GSK?
- What is GSK TTM D&A year-on-year change?
What is GSK annual depreciation & amortization?
The current annual D&A of GSK is $3.26B
What is the all time high annual D&A for GSK?
GSK all-time high annual depreciation & amortization is $3.26B
What is GSK annual D&A year-on-year change?
Over the past year, GSK annual depreciation & amortization has changed by +$405.80M (+14.22%)
What is GSK quarterly depreciation & amortization?
The current quarterly D&A of GSK is $1.04B
What is the all time high quarterly D&A for GSK?
GSK all-time high quarterly depreciation & amortization is $3.06B
What is GSK quarterly D&A year-on-year change?
Over the past year, GSK quarterly depreciation & amortization has changed by +$339.92M (+48.82%)
What is GSK TTM depreciation & amortization?
The current TTM D&A of GSK is $3.60B
What is the all time high TTM D&A for GSK?
GSK all-time high TTM depreciation & amortization is $5.56B
What is GSK TTM D&A year-on-year change?
Over the past year, GSK TTM depreciation & amortization has changed by +$827.29M (+29.83%)